TrialBMC pulmonary medicine2015
Reliever salbutamol use as a measure of exacerbation risk in chronic obstructive pulmonary disease.
Christine R Jenkins et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
31 papers cite it
this paperpooled ittrialcites it